Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of Sanhuang Jingshiming Pill for wet age-related macular degeneration
CTR20200017Phase 2Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Jul 2020
- Countries
- 1
01
Overview
A Phase 2 trial of Sanhuang Jingshiming in exudative macular degeneration, sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Jul 2020; status: completed.
02
Drugs
Sanhuang Jingshiming
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on CTR20200017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200017.